Other
US court orders $834 mn from BMS, Sanofi on Plavix: reports
A Hawaii court ordered Bristol-Myers Squibb and Sanofi to pay the state $834 million over marketing claims for blood thinner, Plavix, according to news reports.
Feb 16, 2021
0
3
News tagged with plavix
Cardiology
Patients do as well on generic antiplatelet drugs as more expensive brand-name product
Generic anti-platelet drugs seem to work as well as a brand name drug for heart patients, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Mar 13, 2018
0
23
Health
High Court ruling may hurt claims of talc link to cancer
A Supreme Court ruling this week could have a "chilling effect" on the many lawsuits filed in St. Louis claiming talcum powder causes a deadly form of cancer in women, including cases under appeal in which stricken women ...
Jun 20, 2017
0
0
Medications
High court sides with drugmaker in Plavix lawsuit
The Supreme Court says hundreds of out-state-residents can't sue drugmaker Bristol-Myers Squibb Co. in California state court over adverse reactions to the blood thinner Plavix.
Jun 19, 2017
0
0
Medical research
Scientists find a key protein that allows Plavix to conquer platelets
Researchers at the UNC School of Medicine have found that the blood platelet protein Rasa3 is critical to the success of the common anti-platelet drug Plavix, which breaks up blood clots during heart attacks and other arterial ...
Feb 23, 2015
0
44
Medications
Hawaii attorney general sues maker of drug Plavix (Update)
Hawaii's attorney general is suing the makers of a widely prescribed blood thinner that he says a significant portion of the state's population has difficulty metabolizing.
Mar 19, 2014
0
0
Medications
Sanofi warns on '13 profit as Q2 earns slump (Update)
Competition from generic drugs continued to hammer French pharmaceutical group Sanofi in the second quarter, the company said Thursday, warning that its full-year earnings could be twice as bad as previous guidance.
Aug 1, 2013
0
0
Medications
Sanofi abandons two drugs after trial failures
Drugmaker Sanofi is abandoning two drugs in the late stages of development after trials revealed they weren't more effective than other therapies.
Jun 3, 2013
0
0
Other
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
May 2, 2013
0
0
Medications
Shopping around brings steep prescription drug savings, report finds
(HealthDay News) —Prescription drug prices at U.S. pharmacies can vary widely, and failing to shop around could result in people overpaying by as much as $100 or more a month on average, depending on the drug, a new study ...
Mar 28, 2013
0
0
Clopidogrel
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix, by Sun Pharmaceuticals under the trade name Clopilet, by Ranbaxy Laboratories under the trade name Ceruvin. It works by irreversibly inhibiting a receptor called P2Y12. Adverse effects include hemorrhage.
This text uses material from Wikipedia, licensed under CC BY-SA
